Effect of Critical Illness on Triglyceride Absorption |
| |
Authors: | Yasmine Ali Abdelhamid MBBS Caroline E. Cousins BSc Jennifer A. Sim B Med Sci Max S. Bellon Dip Med Tech A Dip Nuc Med Nam Q. Nguyen MBBS PhD FRACP Michael Horowitz MBBS PhD FRACP Marianne J. Chapman BMBS PhD FANZCA FCICM Adam M. Deane MBBS PhD FRACP FCICM |
| |
Affiliation: | 1. Department of Critical Care Services, Royal Adelaide Hospital, Adelaide, Australia;2. Discipline of Acute Care Medicine, University of Adelaide, Adelaide, Australia;3. Department of Nuclear Medicine, Royal Adelaide Hospital, Adelaide, Australia;4. Discipline of Medicine, University of Adelaide, Adelaide, Australia |
| |
Abstract: | Background: Adequate nutrition support for critically ill patients optimizes outcome, and enteral feeding is the preferred route of nutrition. Small intestinal glucose absorption is frequently impaired in critical illness. Despite lipid being a major constituent of liquid nutrient administered, there is little information about lipid absorption during critical illness. Objectives: To determine small intestinal lipid, as well as glucose, absorption in critical illness compared with health. Materials and Methods: Twenty‐nine mechanically ventilated critically ill patients and 16 healthy volunteers were studied. Liquid nutrient (60 mL, 1 kcal/mL), containing 200 µL 13C‐triolein and 3 g 3‐O‐methyl‐glucose (3‐OMG), was infused directly into the duodenum at a rate of 2 kcal/min. Exhaled 13CO2 and serum 3‐OMG concentrations were measured at timed intervals over 360 minutes. Lipid absorption was measured as the cumulative percentage dose (cPDR) of 13CO2 recovered at 360 minutes. Glucose absorption was measured as the area under the 3‐OMG concentration curve. Data are median (range) and analyzed using the Mann‐Whitney U and Pearson correlation tests. Results: Lipid absorption was markedly less in the critically ill (cPDR13CO2: patients, 22.6% [0%–100%] vs healthy participants, 40.7% [5.3%–84.7%]; P = .018). While glucose absorption was less at 60 minutes in the critically ill (3‐OMG60: 13.2 [3.5–29.5] vs 21.1 [9.3–31.9] mmol/L·min; P = .003), this was not apparent at 360 minutes (3‐OMG360: 92.7 [54.5–147.9] vs 107.9 [64.0–168.7] mmol/L·min; P = .126). There was no relationship between lipid and glucose absorption. Conclusion: Small intestinal absorption of lipid is diminished during critical illness. |
| |
Keywords: | lipids nutrition critical care research and diseases enteral nutrition |
|
|